Singapore Medical Group Limited is engaged in the operation of medical clinics and provision of general medical services and investment holdings. The Company operates through three segments. Its Health Business segment consists of general ophthalmological services, such as implantable contact lens and cataract surgery; orthopedic services, including treatments for joint and cartilage injuries; oncology services, including the prevention, diagnosis and treatment of cancer; obstetrical and gynecological services, which caters to the wellness of women; otolaryngology services; dermatology services, and general medicine and health screening services. Its Aesthetics Business consists of refractive surgery services; dental services, including general dental services, prosthodontics, orthodontics, implant dentistry, oral surgery and gum treatment, and aesthetics medicine services. Its Others segment consists of group-level corporate services, as well as business consultancy functions.
Ford US Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.